Literature DB >> 2147516

Effects of 8-OH-DPAT, buspirone and ICS 205-930 on feeding in a novel environment: comparisons with chlordiazepoxide and FG 7142.

P J Fletcher1, M Davies.   

Abstract

Previously, the 5-hydroxytryptamine (5-HT)1A receptor agonists, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and buspirone and the 5-HT3 receptor antagonist ICS 205-930 have been shown to exert anxiolytic-like effects in several animal models. In the experiments reported here the effects of these compounds on feeding behaviour and food preference in a novel environment were examined, and compared with the effects of the anxiolytic drug chlordiazepoxide and the anxiogenic compound FG 7142. Chlordiazepoxide significantly reduced the latency to begin eating and prolonged the total time spent eating; chlordiazepoxide also abolished food neophobia, by significantly increasing the time spent eating novel food items. In contrast, FG 7142 significantly increased eating latency and reduced eating duration. Both 8-OH-DPAT and buspirone significantly enhanced eating duration, but unlike chlordiazepoxide eating was directed only towards the familiar food. In addition buspirone, but not 8-OH-DPAT, reduced eating latency. ICS 205-930 significantly increased eating latency and reduced eating duration; however, these effects were observed only at the lowest dose tested. All of these behavioural effects were observed only when animals were unfamiliar with the testing situation, and cannot be accounted for in terms of changes in mechanisms controlling hunger. The behavioural paradigm used in these experiments may induce a competition between the drives to explore a novel environment and to eat. It is suggested that the tendency of buspirone and 8-OH-DPAT to suppress exploratory activity may thus result in enhanced feeding duration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147516     DOI: 10.1007/bf02244094

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Zacopride: anxiolytic profile in rodent and primate models of anxiety.

Authors:  B Costall; A M Domeney; P A Gerrard; M E Kelly; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1988-04       Impact factor: 3.765

2.  The anorectic effect of FG 7142, a partial inverse agonist at benzodiazepine recognition sites, is reversed by CGS 8216 and clonazepam but not food deprivation.

Authors:  S J Cooper
Journal:  Brain Res       Date:  1985-10-28       Impact factor: 3.252

Review 3.  Lesions of the dorsal noradrenergic bundle simultaneously enhance and reduce responsivity to novelty in a food preference test.

Authors:  B J Cole; T W Robbins; B J Everitt
Journal:  Brain Res       Date:  1988-12       Impact factor: 3.252

4.  8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance.

Authors:  C T Dourish; P H Hutson; G A Kennett; G Curzon
Journal:  Appetite       Date:  1986       Impact factor: 3.868

5.  A simple and specific screen for benzodiazepine-like drugs.

Authors:  B P Poschel
Journal:  Psychopharmacologia       Date:  1971

Review 6.  Potential use of drugs modulating 5HT activity in the treatment of anxiety.

Authors:  C R Gardner
Journal:  Gen Pharmacol       Date:  1988

7.  Animal models for the study of anti-anxiety agents: a review.

Authors:  D Treit
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

8.  Exploration of mice in a black and white test box: validation as a model of anxiety.

Authors:  B Costall; B J Jones; M E Kelly; R J Naylor; D M Tomkins
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

9.  Effects of 8-OH-DPAT on motor activity in the rat.

Authors:  V Hillegaart; M L Wadenberg; S Ahlenius
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

10.  Effects of chlordiazepoxide and diazepam on feeding performance in a food-preference test.

Authors:  S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  1 in total

Review 1.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.